ReviewInflammopharmacology2026

Pulmonary fibrosis in post-COVID-19: epithelial-mesenchymal transition as a key mechanism and target for therapy.

R Sanjay Ramanan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.